266 related articles for article (PubMed ID: 32048611)
1. Circular RNA hsa_circ_0056836 functions an oncogenic gene in hepatocellular carcinoma through modulating miR-766-3p/FOSL2 axis.
Li Z; Liu Y; Yan J; Zeng Q; Hu Y; Wang H; Li H; Li J; Yu Z
Aging (Albany NY); 2020 Feb; 12(3):2485-2497. PubMed ID: 32048611
[TBL] [Abstract][Full Text] [Related]
2. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
Jin J; Liu H; Jin M; Li W; Xu H; Wei F
Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
[TBL] [Abstract][Full Text] [Related]
3. Circ_0091581 Promotes the Progression of Hepatocellular Carcinoma Through Targeting miR-591/FOSL2 Axis.
Ji C; Hong X; Lan B; Lin Y; He Y; Chen J; Liu X; Ye W; Mo Z; She Z; Lin S
Dig Dis Sci; 2021 Sep; 66(9):3074-3085. PubMed ID: 33040214
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA circ-FOXP1 induced by SOX9 promotes hepatocellular carcinoma progression via sponging miR-875-3p and miR-421.
Wang W; Li Y; Li X; Liu B; Han S; Li X; Zhang B; Li J; Sun S
Biomed Pharmacother; 2020 Jan; 121():109517. PubMed ID: 31698267
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis.
Gong J; Du C; Sun N; Xiao X; Wu H
J Gene Med; 2021 Jun; 23(6):e3332. PubMed ID: 33783904
[TBL] [Abstract][Full Text] [Related]
6. hsa_circ_0000092 promotes hepatocellular carcinoma progression through up-regulating HN1 expression by binding to microRNA-338-3p.
Pu J; Wang J; Li W; Lu Y; Wu X; Long X; Luo C; Wei H
J Cell Mol Med; 2024 Mar; 28(6):e15010. PubMed ID: 32077624
[TBL] [Abstract][Full Text] [Related]
7. circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression.
Liu G; Guo W; Rao M; Qin J; Hu F; Li K
Cell Transplant; 2020; 29():963689720963948. PubMed ID: 33028110
[TBL] [Abstract][Full Text] [Related]
8. Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway.
Wang F; Xie Z; Zhang N; Ding H; Xiong K; Guo L; Huang H; Wen Z
Bioengineered; 2022 Jan; 13(1):1185-1197. PubMed ID: 35258395
[TBL] [Abstract][Full Text] [Related]
9. Hsa_circ_0101432 promotes the development of hepatocellular carcinoma (HCC) by adsorbing miR-1258 and miR-622.
Zou H; Xu X; Luo L; Zhang Y; Luo L; Yao Y; Xiang G; Huang X; Wang G
Cell Cycle; 2019 Oct; 18(19):2398-2413. PubMed ID: 31095447
[TBL] [Abstract][Full Text] [Related]
10. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR-620.
Li X; Shen M
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(2):555-566. PubMed ID: 30720163
[TBL] [Abstract][Full Text] [Related]
12. Hsa_circ_101280 promotes hepatocellular carcinoma by regulating miR-375/JAK2.
Cao S; Wang G; Wang J; Li C; Zhang L
Immunol Cell Biol; 2019 Feb; 97(2):218-228. PubMed ID: 30302825
[TBL] [Abstract][Full Text] [Related]
13. CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway.
Huang G; Liang M; Liu H; Huang J; Li P; Wang C; Zhang Y; Lin Y; Jiang X
Cell Death Dis; 2020 Dec; 11(12):1065. PubMed ID: 33311442
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA hsa_circ_0003141 promotes tumorigenesis of hepatocellular carcinoma via a miR-1827/UBAP2 axis.
Wang Y; Gao R; Li J; Tang S; Li S; Tong Q; Mao Y
Aging (Albany NY); 2020 May; 12(10):9793-9806. PubMed ID: 32464601
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA hsa_circ_0016788 regulates hepatocellular carcinoma tumorigenesis through miR-486/CDK4 pathway.
Guan Z; Tan J; Gao W; Li X; Yang Y; Li X; Li Y; Wang Q
J Cell Physiol; 2018 Jan; 234(1):500-508. PubMed ID: 29923236
[TBL] [Abstract][Full Text] [Related]
16. Hsa_circ_0079875 functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression.
Liu Y; Luo X; Chen W; Dong Z; Cheng T; Chen L; Ju L; Cai W; Bian Z
Cell Cycle; 2024 Mar; 23(5):519-536. PubMed ID: 38684479
[TBL] [Abstract][Full Text] [Related]
17. Hsa_circ_0000285 knockdown inhibits the progression of hepatocellular carcinoma by sponging miR-582-3p to regulate CCNB2 expression.
Huang J; Zhou H; Diao Y; Yang Z
Hum Exp Toxicol; 2022; 41():9603271221115400. PubMed ID: 35839486
[TBL] [Abstract][Full Text] [Related]
18. hsa_circ_0006916 promotes hepatocellular carcinoma progression by activating the miR-337-3p/STAT3 axis.
Zhou XY; Yang H; Bai YQ; Li XL; Han SY; Zhou BX
Cell Mol Biol Lett; 2020 Nov; 25(1):47. PubMed ID: 33292166
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA CircITCH (has-circ-0001141) suppresses hepatocellular carcinoma (HCC) progression by sponging miR-184.
Guo X; Wang Z; Deng X; Lu Y; Huang X; Lin J; Lan X; Su Q; Wang C
Cell Cycle; 2022 Aug; 21(15):1557-1577. PubMed ID: 35400275
[TBL] [Abstract][Full Text] [Related]
20. Piplartine attenuates the proliferation of hepatocellular carcinoma cells via regulating hsa_circ_100338 expression.
Cheng X; Tian P; Zheng W; Yan X
Cancer Med; 2020 Jun; 9(12):4265-4273. PubMed ID: 32281302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
